Clinica Chimica Acta 1991: Vol 191 Index

9 Pages·1991·1.5 MB·English

Clinica Chimica Acta, Vol. 191
Author index
Akagi, K., see Tsuji, H. (191) 101 human kidney and renal cell carcinoma
Arévalo, A.E., Ibarra-Rubio, M.E., Cruz, C., applying monoclonal antibodies (191) 185
Pena, J.C. and Pedraza-Chaverri, J. Fisken, R.A., Chan, A.W., Hanlon, A. and Mac-
Angiotensin I-converting enzyme activity in Farlane, I.A.
puromycin aminonucleoside-nephrotic syn- Longitudinal changes in serum fructosamine
drome (191) 175 do not parallel those in glycated haemoglobin
Arvan, D.A., see Freund, G. (191) 123 in young adults with insulin-dependent di-
abetes (191) 79
Backman-Gullers, B., Hannestad, U., Nilsson, L. Fournier, A., see Leflon, P. (191) 31
and Sorbo, B. Freund, G. and Arvan, D.A.
Studies on lipoamidase: characterization of Clinical biochemistry of preeclampsia and re-
the enzyme in human serum and breast milk lated liver diseases of pregnancy: a review
(191) 49 (191) 123
Bagrel, D., see Visvikis, A. (191) 221 Fujishima, M., see Tsuji, H. (191) 101
Benraad, T.J., see Tan, A.C.I.T.L. (191) 111
Berger, R., see Schierbeek, H. (191) 39 Goergen, J.-L., see Visvikis, A. (191) 221
Bernard, D.J., see Moyret, C.F. (191) 61 Grewal, G.K. and Oliveira, D.B.G.
Berthod, C., see Rey, F. (191) 21 Why serum F protein is a sensitive and
Bijsterveld, K., see Schierbeek, H. (191) 39 specific marker of liver damage in man (191)
Braillard, K., see Rey, F. (191) 21 93
Buckley, M.G., Sagnella, G.A., Markandu, N.D.,
Singer, D.R.J. and MacGregor, G.A. Hagelberg, S., see Lundsjé, A. (191) 201
Concentrations of N-terminal ProANP in hu- Hanlon, A., see Fisken, R.A. (191) 79
man plasma: evidence for ProANP (1-98) as Hannestad, U., see Backman-Gullers, B. (191) 49
the circulating form (191) 1 Harb, J., see Massoubre, C. (191) 87
Hashimoto, T., Hisazumi, H. and Matsubara, F.
Chan, A.W., see Fisken, R.A. (191) 79 Serum thyroxin binding globulin (TBG)
Chapman, T.E., see Schierbeek, H. (191) 39 changes during 8 MHz local radiofrequency
Chassagne, J., see Moyret, C.F. (191) 61 hyperthermia (191) 107
Chiodoni, G., see Rey, F. (191) 21 Hisazumi, H., see Hashimoto, T. (191) 107
Chollet, P., see Moyret, C.F. (191) 61
Clausen, I., see Engbaek, F. (191) 239 Ibarra-Rubio, M.E., see Arévalo, A.E. (191) 175
Cruz, C., see Arévalo, A.E. (191) 175 Irino, T., see Matsushita, M. (191) 97
Isobe, H., see Kondo, T. (191) 169
Engasser, J.-M., see Visvikis, A. (191) 221 Iwata, K.
Engbaek, F., Sorensen, G.H., MacIntyre, B., One-step sandwich enzyme immunoassay for
Clausen, I., Lund, H.T. and Jastrup, B. human laminin using monoclonal antibodies
Interference of abnormal hemoglobins on the (191) 211
measurement of hemoglobin A,, by ion-ex-
change chromatography (191) 239 Jastrup, B., see Engbaek, F. (191) 239
Fischer, P., Scherberich, J.E. and Schoeppe, W. Kaartinen, V. and Mononen, I.
Comparative biochemical and immunological Detection of aspartylglycosaminuria using
studies on gamma-glutamyltransferases from urine specimens recovered from absorbent
filter paper (191) 15
246
Kajita, M., see Maehara, M. (191) 233 Lectin binding to serum 5’-nucleotidase and
Karu, A.E., see La Belle, M. (191) 153 alkaline phosphatase in liver disease (191) 87
Kasidas, G.P., Nemat, S. and Rose, G.A. Matsubara, F., see Hashimoto, T. (191) 107
Plasma oxalate and creatinine and oxalate/ Matsushita, M., Irino, T. and Maehata, E.
creatinine clearance ratios in normal subjects Enzymatic determination of serum total and
and in primary hyperoxaluria. Evidence for esterified cholesterol with the same reagents
renal hyperoxaluria (191) 67 (191) 97
Kawakami, Y., see Kondo, T. (191) 169 Maurizis, J.-C., see Moyret, C.F. (191) 61
Kitoh, M., see Maehara, M. (191) 233 Meflah, K., see Massoubre, C. (191) 87
Kloppenborg, P.W.C., see Tan, A.C.I.T.L. (191) Mita, H., Tadokoro, K., Yasueda, H. and Shida,
111 T.
Kondo, T., Murakami, K., Isobe, H., Taniguchi, Histamine release with a solid-phase-coupled
N. and Kawakami, Y. allergen (191) 161
A simple enzyme-linked immunoassay of hu- Mok, K.S., see La Belle, M. (191) 153
man carbonic anhydrase I for the study of Mononen, I., see Kaartinen, V. (191) 15
developing erythroid cells (191) 169 Moriniére, P., see Leflon, P. (191) 31
Krauss, R.M., see La Belle, M. (191) 153 Moyret, C.F., Bernard, D.J., Maurizis, J.-C.,
Chassagne, J., Plagne, R. and Chollet, P.
La Belle, M., Mok, K.S., Karu, A.E. and Krauss, Presence of reverse transcriptase in human
R.M. leukemias and lymphomas (191) 61
Increased immunoreactivity of apolipopro- Murai, K., see Tsuji, H. (191) 101
tein B epitopes during prolonged storage of Murakami, K., see Kondo, T. (191) 169
low density lipoproteins (191) 153
Leflon, P., Plaquet, R., Moriniére, P. and Four- Nakashima, K., see Yoshida, Y. (191) 105
nier, A. Nemat, S., see Kasidas, G.P. (191) 67
Determination of aluminium in bone in Nilsson, L., see Backman-Gullers, B. (191) 49
haemodialyzed patients, using inductively
coupled argon plasma emission spectrometry Ohman, S.
(191) 31 Bayes’ theorem should be considered when
Lemarchand-Béraud, T., see Rey, F. (191) 21 making decision limits (191) 115
Lindblad, B.S., see Lundsjé, A. (191) 201 Oliveira, D.B.G., see Grewal, G.K. (191) 93
Lund, H.T., see Engbaek, F. (191) 239 Orsonneau, J.-L., see Massoubre, C. (191) 87
Lundsjé, A., Hagelberg, S., Palmér, K. and Lin- Oster, T., see Visvikis, A. (191) 221
dblad, B.S.
Amino acid profiles by HPLC after filter Palmér, K., see Lundsjé, A. (191) 201
paper sampling: ‘appropriate technology’ for Pedraza-Chaverri, J., see Arévalo, A.E. (191) 175
monitoring of nutritional status (191) 201 Pena, J.C., see Arévalo, A.E. (191) 175
Perrin, D., see Massoubre, C. (191) 87
MacFarlane, I.A., see Fisken, R.A. (191) 79 Plagne, R., see Moyret, C.F. (191) 61
MacGregor, G.A., see Buckley, M.G. (191) 1 Plaquet, R., see Leflon, P. (191) 31
MacIntyre, B., see Engbaek, F. (191) 239
Maehara, M., Kajita, M., Kitoh, M. and Reijngoud, D.J., see Schierbeek, H. (191) 39
Watanabe, K. Rey, F., Chiodoni, G., Braillard, K., Berthod, C.
A_ reversed-phase high-performance liquid and Lemarchand-Béraud, T.
chromatographic method for the determina- Free testosterone levels in plasma and saliva
tion of pyruvate dehydrogenase complex ac- as determined by a direct solid-phase radio-
tivity in human platelets and cultured skin immunoassay: a critical evaluation (191) 21
fibroblasts (191) 233 Rose, G.A., see Kasidas, G.P. (191) 67
Maehata, E., see Matsushita, M. (191) 97
Marc, A., see Visvikis, A. (191) 221 Sagnella, G.A., see Buckley, M.G. (191) 1
Markandu, N.D., see Buckley, M.G. (191) 1 Scherberich, J.E., see Fischer, P. (191) 185
Masliah, C., see Massoubre, C. (191) 87 Schierbeek, H., Bijsterveld, K., Chapman, T.E.,
Massoubre, C., Verdier, P., Meflah, K., Masliah, Van Luiyk, W.H.J., Reijngoud, D.J. and
C., Perrin, D., Orsonneau, J.-L. and Harb, J. Berger, R.
247
Stable isotope dilution analysis of cystine in Ribonuclease activities in liver tissue of pa-
granulocyte suspensions as cysteine: a power- tients with chronic liver diseases (191) 101
ful method for the diagnosis, the followup,
and treatment of patients with cystinosis (191) Van Luijk, W.H.J., see Schierbeek, H. (191) 39
39 Verdier, P., see Massoubre, C. (191) 87
Schoeppe, W., see Fischer, P. (191) 185 Visvikis, A., Goergen, J.-L., Oster, T., Bagrel, D.,
Shida, T., see Mita, H. (191) 161 Wellman, M., Marc, A., Engasser, J.-M. and
Siest, G., see Visvikis, A. (191) 221 Siest, G.
Singer, D.R.J., see Buckley, M.G. (191) 1 gamma-Glutamyltransferase from human
Sdrbo, B., see Backman-Gullers, B. (191) 49 hepatoma cell lines: purification and cell cul-
Serensen, G.H., see Engbaek, F. (191) 239 ture of HepG2 on microcarriers (191) 221
Tadokoro, K., see Mita, H. (191) 161 Watanabe, K., see Maehara, M. (191) 233
Tan, A.C.1.T.L., Kloppenborg, P.W.C. and Ben- Wellman, M., see Visvikis, A. (191) 221
raad, T.J.
Storage and thawing influence plasma levels Yasueda, H., see Mita, H. (191) 161
of immunoreactive atrial natriuretic peptide Yoshida, Y. and Nakashima, K.
(191) 111 Labile HbA,, formation in fractionated
Taniguchi, N., see Kondo, T. (191) 169 erythrocytes in aerobic and anaerobic condi-
Tsuji, H., Murai, K., Akagi, K. and Fujishima, tions (191) 105
M.

Clinica Chimica Acta, Vol. 191
Subject index
Acetyl-CoA Bone
Pyruvate dehydrogenase complex; Lactic aci- Aluminium determination; Argon plasma; Emis-
demia; High-performance liquid chromatogra- sion spectrometry (Leflon, P. (191) 31)
phy; Platelet; Fibroblast (Maehara, M. (191) 233)
Breast milk
Alkaline phosphatase Lipoamidase; Lipoic acid; p-Aminobenzoic acid;
Lectin binding; Serum 5’-nucleotidase; Liver Human serum; Inhibitors (Backman-Gullers, B.
disease (Massoubre, C. (191) 87) (191) 49)
Aluminium determination Carbonic anhydrase I
Bone; Argon plasma; Emission spectrometry Enzyme-linked immunoassay; Erythroid cell
(Leflon, P. (191) 31) (Kondo, T. (191) 169)
Amino acid Cardiac transplant
Blood; Neonatology; Nutritional status (Lundsj6, ProANP (1-98); Essential hypertension; Renal
A. (191) 201) failure; Volume expansion; Gel filtration (Buck-
ley, M.G. (191) 1)
p-Aminobenzoic acid
Lipoamidase; Lipoic acid; Human serum; Breast Cell culture
milk; Inhibitors (Backman-Gullers, B. (191) 49) gamma-Glutamyltransferase; Human hepatoma
cell line; HepG2; PLC/PRF/5; Microcarrier
Aminonucleoside-nephrosis (Visvikis, A. (191) 221)
Angiotensin converting enzyme; Nephrotic syn-
drome; Puromycin aminonucleoside; Nephrotic Clearance
rat. (Arévalo, A.E. (191) 175) Plasma oxalate; Primary hyperoxaluria (Kasidas,
G.P. (191) 67)
Angiotensin converting enzyme
Nephrotic syndrome; Puromycin aminonucleo- Cysteine
side; Aminonucleoside-nephrosis; Nephrotic rat. Cystinosis; Isotope dilution; Electron impact
(Arévalo, A.E. (191) 175) mass spectrometry; Tri-butylphosphine (Schier-
beek, H. (191) 39)
Apolipoprotein B
Low density lipoprotein (La Belle, M. (191) 153) Cystinosis
Isotope dilution; Electron impact mass _ spec-
Argon plasma trometry; Tri-butylphosphine; Cysteine (Schier-
Aluminium determination; Bone; Emission spec- beek, H. (191) 39)
trometry (Leflon, P. (191) 31)
Diabetes mellitus
Aspartylglycosaminuria Hemoglobinopathy; Ion-exchange chromatogra-
Sample handling; High-performance liquid chro- phy; High-pressure liquid chromatography (En-
matography (Kaartinen, V. (191) 15) gbaek, F. (191) 239)
Blood Electron impact mass spectrometry
Amino acid; Neonatology; Nutritional status Cystinosis; Isotope dilution; Tri-butylphosphine;
(Lundsjé, A. (191) 201) Cysteine (Schierbeek, H. (191) 39)
250
Emission spectrometry phy; High-pressure liquid chromatography (En-
Aluminium determination; Bone; Argon plasma gbaek, F. (191) 239)
(Leflon, P. (191) 31)
HepG2
Enzyme-linked immunoassay gamma-Glutamyltransferase; Human hepatoma
Carbonic anhydrase I; Erythroid cell (Kondo, T. cell line; PLC/PRF/5; Cell culture; Microcar-
(191) 169) rier (Visvikis, A. (191) 221)
Erythroid cell High-performance liquid chromatography
Carbonic anhydrase I; Enzyme-linked immuno- Aspartylglycosaminuria; Sample handling (Kaar-
assay (Kondo, T. (191) 169) tinen, V. (191) 15)
Essential hypertension Pyruvate dehydrogenase complex; Acetyl-CoA;
ProANP (1-98); Cardiac transplant; Renal Lactic acidemia; Platelet; Fibroblast (Maehara,
failure; Volume expansion; Gel filtration (Buck- M. (191) 233)
ley, M.G. (191) 1)
High-pressure liquid chromatography
Fibroblast Diabetes mellitus; Hemoglobinopathy; Ion-ex-
Pyruvate dehydrogenase complex; Acetyl-CoA; change chromatography (Engbaek, F. (191) 239)
Lactic acidemia; High-performance liquid chro-
matography; Platelet (Maehara, M. (191) 233) Histamine
Histamine release (Mita, H. (191) 161)
Free hormone radioimmunoassay
Free testosterone; Saliva testosterone (Rey, F. Histamine release
(191) 21) Histamine (Mita, H. (191) 161)
Free testosterone Human hepatoma cell line
Saliva testosterone; Free hormone _ radioim- gamma-Glutamyltransferase; HepG2; PLC/
munoassay (Rey, F. (191) 21) PRF/5; Cell culture; Microcarrier (Visvikis, A.
(191) 221)
Fructosamine
Insulin-dependent diabetes; Glycated hemo- Human kidney
globin (Fisken, R.A. (191) 79) gamma-Glutamyltransferase (EC 2.3.2.2); Mono-
clonal antibody; Renal cell carcinoma; Isoen-
Gel filtration zyme (Fischer, P. (191) 185)
ProANP (1-98); Essential hypertension; Cardiac
transplant; Renal failure; Volume expansion Human serum
(Buckley, M.G. (191) 1) Lipoamidase; Lipoic acid; p-Aminobenzoic acid;
Breast milk; Inhibitors (Backman-Gullers, B.
gamma-Glutamyltransferase (191) 49)
Human hepatoma cell line; HepG2; PLC/
PRF/5; Cell culture; Microcarrier (Visvikis, A. Immunoassay
(191) 221) Sandwich enzyme; Monoclonal antibody (Iwata,
K. (191) 211)
gamma-Glutamyltransferase (EC 2.3.2.2)
Monoclonal antibody; Renal cell carcinoma; Inhibitors
Human kidney; Isoenzyme (Fischer, P. (191) 185) Lipoamidase; Lipoic acid; p-Aminobenzoic acid;
Human serum; Breast milk (Backman-Gullers,
Glycated hemoglobin B. (191) 49)
Insulin-dependent diabetes; Fructosamine (Fis-
ken, R.A. (191) 79) Insulin-dependent diabetes
Fructosamine; Glycated hemoglobin (Fisken,
Hemoglobinopathy R.A. (191) 79)
Diabetes mellitus; Ion-exchange chromatogra-
lon-exchange chromatography Monoclonal antibody
Diabetes mellitus; Hemoglobinopathy; High- gamma-Glutamyltransferase (EC 2.3.2.2); Renal
pressure liquid chromatography (Engbaek, F. cell carcinoma; Human kidney; Isoenzyme
(191) 239) (Fischer, P. (191) 185)
Isoenzyme Sandwich enzyme; Immunoassay (Iwata, K. (191)
gamma-Glutamyltransferase (EC 2.3.2.2); Mono- 211)
clonal antibody; Renal cell carcinoma; Human
kidney (Fischer, P. (191) 185) Neonatology
Amino acid; Blood; Nutritional status (Lundsj6,
Isotope dilution A. (191) 201)
Cystinosis; Electron impact mass spectrometry;
Tri-butylphosphine; Cysteine (Schierbeek, H. Nephrotic rat.
(191) 39) Angiotensin converting enzyme; Nephrotic syn-
drome; Puromycin aminonucleoside;
Lactic acidemia Aminonucleoside-nephrosis (Arévalo, A.E. (191)
Pyruvate dehydrogenase complex; Acetyl-CoA; 175)
High-performance liquid chromatography;
Platelet; Fibroblast (Maehara, M. (191) 233) Nephrotic syndrome
Angiotensin converting enzyme; Puromycin
Lectin binding aminonucleoside; Aminonucleoside-nephrosis;
Serum 5’-nucleotidase; Alkaline phosphatase; Nephrotic rat. (Arévalo, A.E. (191) 175)
Liver disease (Massoubre, C. (191) 87)
Nutritional status
Leukemia Amino acid; Blood; Neonatology (Lundsjé, A.
Reverse transcriptase; Purification assay; Lym- (191) 201)
phoma (Moyret, C.F. (191) 61)
Plasma oxalate
Lipoamidase Clearance; Primary hyperoxaluria (Kasidas, G.P.
Lipoic acid; p-Aminobenzoic acid; Human (191) 67)
serum; Breast milk; Inhibitors (Backman-Gullers,
B. (191) 49) Platelet
Pyruvate dehydrogenase complex; Acetyl-CoA;
Lipoic acid Lactic acidemia; High-performance liquid chro-
Lipoamidase; p-Aminobenzoic acid; Human matography; Fibroblast (Maehara, M. (191) 233)
serum; Breast milk; Inhibitors (Backman-Gullers,
B. (191) 49) PLC/PRF/5
gamma-Glutamyltransferase; Human hepatoma
Liver disease cell line; HepG2; Cell culture; Microcarrier
Lectin binding; Serum 5’-nucleotidase; Alkaline (Visvikis, A. (191) 221)
phosphatase (Massoubre, C. (191) 87)
Primary hyperoxaluria
Low density lipoprotein Plasma oxalate; Clearance (Kasidas, G.P. (191)
Apolipoprotein B (La Belle, M. (191) 153) 67)
Lymphoma ProANP (1-98)
Reverse transcriptase; Purification assay; Leu- Essential hypertension; Cardiac transplant; Re-
kemia (Moyret, C.F. (191) 61) nal failure; Volume expansion; Gel filtration
(Buckley, M.G. (191) 1)
Microcarrier
gamma-Glutamyltransferase; Human hepatoma Purification assay
cell line; HepG2; PLC/PRF/5; Cell culture Reverse transcriptase; Leukemia; Lymphoma
(Visvikis, A. (191) 221) (Moyret, C.F. (191) 61)
252
Puromycin aminonucleoside Saliva testosterone
Angiotensin converting enzyme; Nephrotic syn- Free testosterone; Free hormone _ radioim-
drome; Aminonucleoside-nephrosis; Nephrotic munoassay (Rey, F. (191) 21)
rat. (Arévalo, A.E. (191) 175)
Sample handling
Pyruvate dehydrogenase complex Aspartylglycosaminuria; High-performance liq-
Acetyl-CoA; Lactic acidemia; High-performance uid chromatography (Kaartinen, V. (191) 15)
liquid chromatography; Platelet; Fibroblast
(Maehara, M. (191) 233) Sandwich enzyme
Immunoassay; Monoclonal antibody (Iwata, K.
Renal cell carcinoma (191) 211)
gamma-Glutamyltransferase (EC 2.3.2.2); Mono-
clonal antibody; Human kidney; Isoenzyme Serum 5’- nucleotidase
(Fischer, P. (191) 185) Lectin binding; Alkaline phosphatase; Liver dis-
ease (Massoubre, C. (191) 87)
Renal failure
ProANP (1-98); Essential hypertension; Cardiac Tri-butylphosphine
transplant; Volume expansion; Gel filtration Cystinosis; Isotope dilution; Electron impact
(Buckley, M.G. (191) 1) mass spectrometry; Cysteine (Schierbeek, H.
(191) 39)
Reverse transcriptase
Purification assay; Leukemia; Lymphoma Volume expansion
(Moyret, C.F. (191) 61) ProANP (1-98); Essential hypertension; Cardiac
transplant; Renal failure; Gel filtration (Buck-
ley, M.G. (191) 1)